Matthew Mao’s practice focuses on acquisition and leveraged debt financings and related corporate transactions for private equity sponsors and their portfolio companies, as well as public and private companies.

He is a highly regarded finance lawyer, with nearly 15 years’ experience advising on leveraged buyouts, liability management and capital solutions for clients on their most strategically significant transactions.

He also brings extensive experience as a former in-house counsel working on financings, capital raises, and partnerships, most recently as Senior Vice President, Legal, for Fanatics, a licensed sports apparel, collectibles, and gaming company. Beforehand, he worked at Hillspire as Senior Legal Director for Corporate Transactions and at MacAndrews & Forbes as Vice President, Legal.

Matt originally joined Cleary Gottlieb in 2010 as an associate and transitioned in-house in 2018. In July 2024, he rejoined the firm as a partner.

Notable Experience

  • Warburg Pincus in financings for numerous acquisitions, recapitalizations, and refinancings, including Redwood Software, CityMD, Labstat, Gabriel Brothers, Hygiena, Endurance International Group, and Universal Services of America.

  • Belron, a leading vehicle glass repair, replacement, and recalibration company, in its €8.1 billion (equivalent) refinancing and dividend recapitalization, which, according to PitchBook LCD, is the largest dividend recapitalization on record.

  • Medtronic, a global medical technology company, in connection with the financing for its $42.9 billion acquisition of Covidien.

  • Vericast, a leading marketing technology partner for businesses, in financings of its acquisitions of RetailMeNot and MaxPoint, and in refinancings of its credit facilities and senior notes.

  • Kindred Healthcare, a home health and hospital provider, in financings and its sale to Humana, TPG Capital and Welsh, Carson, Anderson & Stowe.

  • Groupe Acticall, an integrated services group, in its financing for its acquisition of Sitel from Onex and other shareholders.

See More

Publications